REG - Zotefoams PLC - Group CFO succession

RNS Number : 2912A Zotefoams PLC 22 September 2025 Zotefoams plc('Zotefoams' or 'Group')Group CFO succession22 September 2025 - Further to the announcement of 30 April 2025 regarding the succession of the Group Chief Financial Officer, Zotefoams confirms that Nick Wright has joined the business as CFO Designate and has been appointed to the Board as Executive Director.Nick will assume the role of CFO on 1 November 2025, following the retirement of Gary McGrath on 31 October 2025.Enquiries:Zotefoams plc+44 (0) 208 664 1600Ronan Cox, Group CEOGary McGrath, Group CFOIFC Advisory+44 (0) 203 934 6630Graham HerringTim MetcalfeZach CohenAbout Zotefoams plcZotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam technology, delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide across three market verticals, Consumer & Lifestyle, Transport & Smart Technologies, and Construction & Other Industrial. Zotefoams uses its own materials to manufacture T-FIT® advanced insulation for demanding industrial markets.Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).www.zotefoams.comAZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END BOASEEFDEEISEDU